Gout
📧 Sign up to get email alerts when something new happens for Gout.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-01Clinical Trial Results: A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout [Phase 4]
Phase 4 trial comparing pegylated uricase (pegloticase) given every 4 weeks with methotrexate vs every 2 weeks with methotrexate for uncontr…
-
CLINICAL_TRIALS trial_result · 2026-06-22Clinical Trial Results: To Evaluate the Influence of (LUA Probiotics) on Uric Acid
Clinical trial results evaluating the influence of LUA Probiotics on uric acid in gout patients have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-10Clinical Trial Results: Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia [Phase 1, Phase 2]
Open-label pharmacokinetic, pharmacodynamic, and drug-drug interaction study of dotinurad with allopurinol in gout patients with hyperuricem…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Long-Term Risk of Gout in Living Kidney Donors
A completed clinical trial update assessing the long-term risk of gout among living kidney donors.
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: A Study of Dotinurad Versus Allopurinol in Tophaceous Gout [Phase 3]
A Phase 3 clinical trial comparing dotinurad to allopurinol for tophaceous gout is currently recruiting, sponsored by Crystalys Therapeutics…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Study of the Correlation Between UltraSonography and Dual-Energy Computed Tomography Assessment of Urate Deposit [NA]
A completed clinical trial evaluating the correlation between ultrasound and dual-energy CT in outlining urate deposits in gout patients.
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ Fusion Protein in the Treatment of Acute Gout [NA]
This document reports the completion of a clinical trial evaluating a recombinant human TNF receptor II fusion protein for acute gout.
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout [Phase 4]
This completed Phase 4 trial assessed whether pegloticase given every 4 weeks with methotrexate is non-inferior to pegloticase every 2 weeks…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968 [Phase 1]
This Phase 1 trial update reports the completion of a single-dose study of LEO 158968 evaluating efficacy, safety, tolerability, pharmacokin…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of SHR4640 tablets in combination with febuxostat 40 mg for primary gout and hyper…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Clinical Trial of BR2251 Tablets for Patients With Primary Gout and Hyperuricemia [Phase 2]
Phase 2 clinical trial update for BR2251 tablets in primary gout with hyperuricemia; the study is currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Prediction of Patient Deterioration Using Machine Learning
Completed clinical trial evaluating a machine learning model to predict patient deterioration in hospitalized patients with infection and he…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Prediction of 30-Day Readmission Using Machine Learning
A completed Brigham and Women's Hospital trial investigates using machine learning to predict 30-day readmission across multiple conditions,…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Phone-Based Based Walk With Ease Program for Adults With Arthritis [NA]
Completed clinical trial evaluating a phone-based Walk With Ease program for adults with arthritis, with results posted.
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of AR882 with a xanthine oxidase inhibitor co-administration in gout patients who …
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines - (DREAM) Probenecid vs Allopurinol
A completed clinical trial comparing probenecid and allopurinol for repurposing toward Alzheimer's therapies; results posted February 27, 20…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness [Phase 4]
Phase 4 clinical trial evaluating HLA-B*58:01-guided therapy for gout to assess effectiveness, safety, and cost-effectiveness; recruitment n…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout [Phase 2, Phase 3]
Phase 2b/3 trial evaluating ABP-671, a URAT1 inhibitor, for gout has completed according to the update.
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia [Phase 2]
A Phase 2 trial evaluated different doses of LC350189 for efficacy and safety in patients with gout and hyperuricemia; trial results have be…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy II [Phase 3]
A Phase 3 study of SEL-212 in patients with chronic gout refractory to conventional therapy has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Gout in the ED and Improving Research Participation [NA]
This clinical trial update reports on a gout study conducted in the emergency department, including efforts to improve participation in rese…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Rural Hospital-Level Care at Home for Acutely Ill Adults [NA]
This clinical trials.gov entry notes that the Brigham and Women's Hospital study on rural hospital-level care at home for acutely ill adults…
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients [Phase 3]
LG Chem reports completion of a Phase 3, placebo-controlled trial of tigulixostat in patients with gout and hyperuricemia; the study status …
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults [Phase 3]
A Phase 3 clinical trial evaluating HR091506 tablets for gout with hyperuricemia in adults has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL) [Phase 4]
Phase 4 open-label trial evaluating co-administration of KRYSTEXXA (pegloticase) with methotrexate in patients with uncontrolled gout; study…